UnknownPhase 4NCT00552851

Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant

Studying Acromegaly

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Wuerzburg
Principal Investigator
Bruno Allolio, MD
University of Wuerzburg. Department of Endocrinology
Intervention
pegvisomant(drug)
Enrollment
4 enrolled
Eligibility
18 years · All sexes
Timeline
2006 – 2010

Study locations (1)

Collaborators

Pfizer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00552851 on ClinicalTrials.gov

Other trials for Acromegaly

Additional recruiting or active studies for the same condition.

See all trials for Acromegaly →

← Back to all trials